Home › NCT07619391

MyCap Mobile Application for Tracking Time Burden of Treatment for Patients With Pancreatic Cancer

A Mobile App for Tracking Time Burden of Pancreatic Cancer Treatment: A Single-Arm Feasibility Study

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* Adults ≥ 18 years old
* Diagnosed with pancreatic adenocarcinoma undergoing active treatment or planning to start active treatment within the next 30 days
* English speaking
* Access to a smartphone (Android or iOS)

Exclusion Criteria:

* Prisoners
* Patients undergoing cancer surveillance

About the study

This clinical trial tests the feasibility of using the MyCap mobile application (app) for tracking time burden from treatment for patients with pancreatic cancer. Pancreatic cancer is best treated with many care teams, such as medical oncology and surgery, requiring patients to dedicate significant time coordinating appointments among different doctors. This time commitment is referred to as time toxicity, defined as the time spent undergoing cancer-related medical care, such as emergency visits, ambulatory care, lab and infusion visits, hospitalizations, and the commuting and waiting times associated with each. At present, time toxicity is still understudied within the medical literature, with no gold standard established for the method of measurement. The MyCap mobile app may be a feasible way to track the time burden from treatment for patients with pancreatic cancer.

What is being tested

• Electronic Health Record Review (other)
• Smartphone Application-based Intervention (behavioral)
• Survey Administration (other)

Sponsor: Ohio State University Comprehensive Cancer Center · Participants: 30 · Started: Mar 10, 2026

Contact the study team

• The Ohio State University Comprehensive Cancer Center · Phone: 800-293-5066

Official record on ClinicalTrials.gov — NCT07619391

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.